Mainland China

Glory Star Announces Receipt of Non-Binding Going Private Proposal

BEIJING, March 14, 2022 /PRNewswire/ -- Glory Star New Media Group Holdings Limited, ("Glory Star" or the "Company") (Nasdaq: GSMG), a leading digital media platform and content-driven e-commerce company inChina, today announced that its Board of Directors has received a preliminary non-binding p...

2022-03-14 19:00 2202

Boqii Announces Senior Management Change

SHANGHAI, March 14, 2022 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE: BQ), a leading pet-focused platform inChina, today announced that Mr.Lijun Zhou has resigned from his position as the Company's Vice President and all his roles as a director or an officer of the appl...

2022-03-14 19:00 2138

JinkoSolar Receives UNGC Best Practices Sustainable Award 2021

SHANGHAI, March 14, 2022 /PRNewswire/ -- JinkoSolar Holding Co., Ltd, ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, announced that it has won the "UGGC Best Practices Sustainability Awards 2021" for the first time, in ...

2022-03-14 18:57 2026

CHINA Season 2: A Retrospective of International Friends in Chinese History, Unfolding Chinese Stories in a Historical and Cultural Documentary

CHANGSHA, China, March 14, 2022 /PRNewswire/ -- Major historical and humanities documentary - CHINA - by Mango TV and Hunan TV, is wrapping up its second season onMarch 15. This season unfolded numerous Chinese stories, including journeys of well-known international friends who have contributed t...

2022-03-14 18:39 3100

Zhihu Inc. Reports Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results

BEIJING, March 14, 2022 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH), the operator of Zhihu, a leading online content community inChina, today announced its unaudited financial results for the quarter and fiscal year endedDecember 31, 2021. Fourth Quarter and Full Year 2021 H...

2022-03-14 18:00 3062

Viomi Technology Co., Ltd to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, March 28, 2022

GUANGZHOU, China, March 14, 2022 /PRNewswire/ -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ: VIOT), a leading IoT @ Home technology company inChina, today announced that it will report its fourth quarter and full year 2021 unaudited financial results onMonday, March 28, 2022, be...

2022-03-14 17:00 2472

Hexvix® Has Obtained CDE Approval for the Inclusion In the Clinical Real-world Evidence Pilot Study

SHANGHAI, March 14, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases, announced that the Hainan Provincial Medical Products...

2022-03-14 14:25 1810

Impact Therapeutics Announces Completion of Series D1 Financing

SHANGHAI, March 14, 2022 /PRNewswire/ -- IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, announced the successful completion of its Series D1 financing. Institutional investors that par...

2022-03-14 12:43 2243

ZIM to Launch ZIM eCommerce Baltimore eXpress (ZXB), a New Speedy eCommerce service from China and South-East Asia to the US East Coast

The New Service Expands ZIM's Speedy Premium Services for eCommerce Customers HAIFA, Israel, March 14, 2022 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd.  (NYSE: ZIM) announced today the launch of  ZIM Ecommerce Baltimore Express (ZXB), a new and speedy e-commerce ser...

2022-03-14 10:00 3326

InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Waldenström's Macroglobulinemia in China

BEIJING, March 13, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) accepted a supplemental New Drug Application (sNDA) for Bruton's tyros...

2022-03-14 08:30 2083

CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer

* GAVRETO is the first and only selective rearranged during transfection (RET) inhibitor approved inChina for the treatment of RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC) * The labeled indications of GAVRETO have been expanded after it was approved by...

2022-03-14 08:05 3914

Latest Study Shows Advantages of CanSinoBIO's Convidecia™ as Heterologous Booster against Omicron Variant

TIANJIN, China, March 14, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced that medRxiv, a preprint platform for preliminary biomedical research, published an academic paper1 on the efficacy of CanSinoBIO's Recombinant COVID-19 Vaccine ("Ad5-n...

2022-03-14 08:00 3349

Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea

SHANGHAI, March 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific markets, announced today that...

2022-03-14 08:00 4363

CIMC helps HK battle pandemic by offering over 2,000 units of modular buildings

SHENZHEN, China, March 14, 2022 /PRNewswire/ -- CIMC Modular Building System will provide a total of 2,076 units of modular buildings to helpHong Kong fight against the COVID-19 pandemic. Modular transitional house being hoisted  

2022-03-14 07:27 4130

Ascletis Announces Further Expansion of Ritonavir Oral Tablet Production Capacity to 530 Million Tablets Per Year

HANGZHOU, China and SHAOXING, China, March 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, HKEX: 1672) today announces that it has further expanded its ritonavir oral tablet production capacity to approximately 530 million tablets per year, to meet the potential escalation in the domesti...

2022-03-13 18:30 4294

Crowdfunding Campaign of CR-Scan Lizard Coming to an End with Creality's Continuous Trend Leading

SHENZHEN, China, March 12, 2022 /PRNewswire/ -- In February, Creality launched the crowdfunding campaign for 3D scanner - CR-Scan Lizard on Kickstarter. The campaign made a stir among users with 1000 units in 17 minutes, and1 million dollars in 4 hours. Till now, Creality has received more than 2...

2022-03-12 03:32 5618

China Matters produced the animated video series 'The 24 Solar Terms in Poetry and Painting'

BEIJING, March 11, 2022 /PRNewswire/ -- China Matters animation team produced the animated video seriesThe 24 Solar Terms in Poetry and Painting, which illustrates the Chinese solar terms through dynamic Chinese paintings and classical poems translated by Dr. Xu Yuanchong. The five solar terms in...

2022-03-11 21:33 5696

NMPA Clears IND for First T-Cell Receptor (TCR) T Cell Therapy to Treat Hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC)

SINGAPORE, March 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG"), a leading biotechnology company, today announced that the China National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for SCG101, the company's first T-...

2022-03-11 21:07 5317

Happiness Development Announces $6.7 Million Registered Direct Offering To Support Its Auto Business

NANPING, China, March 11, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) an emerging and diversified company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing sol...

2022-03-11 21:00 6071

Shenzhen Catalyst Petrochemical CO., LTD. Expands Partnership with Cnooc&Shell Petrochemical Co., Ltd

SHENZHEN, China, March 11, 2022 /PRNewswire/ -- SCPC (Shenzhen Catalyst Petrochemical CO., LTD.) and Cnooc&Shell Petrochemical Co., Ltd(CSPC) reached an important cooperation intention on the development of new HDPE products and metallocene Catalyst products. "SCPC is honored that CSPC has chose...

2022-03-11 20:37 3922

Week's Top Stories